Weifa ASA announced the launch of Ibux(R) 200 mg soft capsules, a line extension to the already well established Ibux(R) range. The launch will be supported by a solid communications campaign towards consumers. Ibux(R) 200 mg soft capsules comes in addition to the 400 mg soft capsules, 200 mg tablets and 400 mg tablets, 20 mg suspension, as well as the Ibux(R) range of gels. The product represents a new opportunity in that the innovative soft capsules can now be used by children down to 6 years of age. It contains ibuprofen and is indicated for short term treatment for mild to moderate pain and fever. The soft capsules are small in size and have no taste. Its content is already dissolved and is therefore quickly absorbed.